AGENDA Information of Event Schedule
Focusing on the design and manufacture of medical devices alongside factors affecting that industry (e.g., regulatory, M&A, quality, legislative), coupled with a keen awareness of challenges associated with the space, the MPO Summit presents a comprehensive agenda that targets many of today's most important issues impacting stakeholders.
7:00-8:40 a.m.
Registration & Continental Breakfast
8:45-9:00 a.m.
9:00-9:45 a.m.
State of the Industry
With an emphasis on M&A activity within the industry among OEMs and the supporting supply chain, this session will highlight the current state of affairs within the medical device manufacturing sector. Key data points and trends will be featured in this opening session, enabling predictions for future activity within the industry.
9:45-10:45 a.m
A Deep Dive into the Medtech Industry Consolidation Trends
This panel will expand upon the main points revealed during the State of the Industry session to determine what the findings mean for both medical device OEMs and their service provider partners. Discussion among the panel will help position the key takeaways from the previous session through the lens of actual industry representatives.
Moderated by Daniel S. Wittenberg
11:30 a.m.-12:15 p.m.
Extending Your Global Reach and Minimizing Your Compliance Exposure at Home
MDSAP (the Medical Device Single Audit Program) helps medical device manufacturers cast a broader net into global markets with minimum effort. It is a highly structured program that has gained traction since 2016 and is now building momentum with greater recognition. Building on the framework and success of the MDSAP program, the U.S. FDA has adopted ISO 13485 as the recognized framework for design and manufacturing compliance for medical devices with recent announcements of the Quality System Management Regulations (QMSR), replacing the Quality System Regulation promulgated in 1996. This session will highlight history, background, summaries of current and historical activities, and personal insights from conversations with regulatory leaders on what manufacturers should be doing now and what to expect from FDA and the most current perspectives. It will also cover how participation in the MDSAP program will not only build strength in your system for improvement but will prevent scheduled visits from FDA as long as you are participating—a clear and measurable benefit.
1:45-2:45 p.m.
EY’s Pulse of the Industry—Presentation and Panel Discussion
A comprehensive look at the EY report’s findings with a focus on the trends driving change within the industry. From digital healthcare to regulatory shifts, this overview of the happenings within medtech will help shape expectations of what’s ahead for the sector. Following the presentation, a panel will focus on the points highlighted during the presentation and discuss their impact on the medtech sector. Using the report’s findings as the conversation pathway, this group of industry representatives will reflect on how factors such as digital health and regulatory changes, along with numerous other variables, will play a role in shaping healthcare technology.
Presented and moderated by Mark Ginestro.
2:45-3:30 p.m.
Session 6
4:15-5:15 p.m.
The Digital Transformation of Medtech
As more of the healthcare landscape shifts to a digitally supported industry, the medical device sector needs to assist this movement with the latest connected technologies. Unfortunately, this path is filled with many challenges, including cybersecurity, privacy concerns, data collection and management, interoperability, and more. Hear from industry experts closely involved in this transformation on their thoughts of what’s happening now and where the industry’s headed.
Moderated by Christopher Lueken
5:30-7:00
7:30-9:00 a.m.
Registration & Continental Breakfast
9:00-10:00 a.m.
Resolving the Disconnect in the Supply Chain
The pandemic exposed the warts in a medical device manufacturing supply chain. Those companies with well-established relationships fared better than those without them. Ease of communication seemed to be paramount, while supply chain geography was a point of focus for many as well. This panel will discuss the vision for the new supply chain make-up and the implications for those involved, from OEM to service provider.
10:00-10:45 a.m
Securing Today’s Digital Manufacturing Floor
Ransomware attacks have only grown in frequency over the past several years. The impact on the medical device manufacturing sector is no different. Companies must ensure their facilities are as protected as possible from digital threats. While prevention can be expensive, it pales in comparison to a breach, so ensuring the production floor is safe is paramount. This session will provide insights on what leaders at medtech manufacturing firms must keep in mind.
11:30 a.m.-12:30 p.m.
Considering Sustainability and Recyclability in Business Planning
Materials and manufacturing practices are coming under the microscope by a number of stakeholders, from regulatory agencies to medical device firms. As such, changes are happening in terms of the selection of materials and the avoidance of others (such as PFAS). Meanwhile, waste is gaining greater attention and solutions are in demand. This session will look at the impact of changing needs within the medical device sector with a primary focus on materials, waste, recycling, and sustainability.
12:30
End of Conference